DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Monoclonal Antibodies Market 2016-2020" report to their offering.
The analysts forecast the global monoclonal antibodies (mAbs) market to grow at a CAGR of 9.84% during the period 2016-2020.
The report covers the present scenario and the growth prospects of the global monoclonal antibodies (mAbs) market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded mAbs and biosimilars used to treat cancer, autoimmune and inflammatory diseases, respiratory diseases, and ophthalmology.
Questions Answered:
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
Companies Mentioned Include:
- AbbVie
- Amgen
- Bristol-Myers Squibb
- F. Hoffmann-La Roche
- Johnson & Johnson
- Merck
- AbGenomics
- ADC Therapeutics
- Agensys
- Alexion Pharmaceuticals
- ALMAC Group
- Ambrx
- Astellas Pharma
- AstraZeneca
- Bayer HealthCare
- Biogen
- Celgene
- Celldex Therapeutics
- Daiichi Sankyo
- Eisai
- Eli Lilly
- Formation Biologics
- Genmab
- GlaxoSmithKline
-
Human Genome Sciences
Report Structure:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: mAbs: Overview
PART 06: Market landscape
PART 07: Market segmentation by type of mAbs
PART 08: Market segmentation by application
PART 09: Geographical segmentation
PART 10: Key leading countries
PART 11: Pipeline portfolio
PART 12: Market drivers
PART 13: Impact of drivers
PART 14: Market challenges
PART 15: Impact of drivers and challenges
PART 16: Market trends
PART 17: Vendor landscape
PART 18: Appendix
PART 19: About the Author
For more information visit http://www.researchandmarkets.com/research/gktctr/global_monoclonal
